Literature DB >> 9163667

Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines.

E Battistini1, G Dini, C Savioli, A Morando, A Gandolfo, Z Kotitsa, A Garaventa, G A Rossi.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathological entity with well-defined diagnostic criteria, which can be idiopathic or produced by a variety of biological processes. We describe the occurrence of BOOP in three children, one with acute lymphoblastic leukaemia and two with acute promyelocytic leukaemia. In the three patients, BOOP developed 10-20 days after a course of therapy with cytosine arabinoside and anthracyclines. The possible relationships between the small conducting airway lesions, lung toxic reaction to the drugs and/or nonidentified infectious agents are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163667     DOI: 10.1183/09031936.97.10051187

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Pediatric Acute Respiratory Distress Syndrome and Hypersensitivity Pneumonitis Related to E-cigarette Vaping.

Authors:  Binh Phung; Anh Lam
Journal:  J Pediatr Intensive Care       Date:  2019-11-28

3.  Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma.

Authors:  Manuel Cobo Dols; Silvia Gil Calle; Immaculada Alés Díaz; Ester Villar Chamorro; Julia Alcaide García; Vanesa Gutiérrez Calderón; Manuel Benavides Orgaz
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

4.  An unusual radiologic pattern of cryptogenic organizing pneumonia: diffuse pulmonary nodules in a leukemia patient.

Authors:  Kai Hsiung Ko; Hsian He Hsu; Woei Yau Kao; Ching Feng Chang; Ming Fang Cheng; Guo Shu Huang
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.